PPA is a common clinical syndrome in those with GRN mutations (44% in the GENFI cohort) but uncommon in both C9orf72 and MAPT mutations (only one case in the GENFI cohort in both genetic groups). The gene discussed is GRN; the disease is primary progressive aphasia.